NOVEL DERIVATIVES OF PURINIC AND PYRIMIDINIC ANTIVIRAL AGENTS AND USE THEREOF AS POTENT ANTICANCER AGENTS
申请人:Ramot at Tel-Aviv University Ltd.
公开号:EP2142548A1
公开(公告)日:2010-01-13
ACYLATED DERIVATIVE OF THE PURINIC ANTIVIRAL AGENT ACICLOVIR AND USE THEREOF AS A POTENT ANTICANCER AGENT
申请人:Ramot at Tel Aviv University Ltd.
公开号:EP2142548B1
公开(公告)日:2016-05-25
US9334272B2
申请人:——
公开号:US9334272B2
公开(公告)日:2016-05-10
[EN] NOVEL DERIVATIVES OF PURINIC AND PYRIMIDINIC ANTIVIRAL AGENTS AND USE THEREOF AS POTENT ANTICANCER AGENTS<br/>[FR] NOUVEAUX DÉRIVÉS D'AGENTS ANTIVIRAUX PURIQUES ET PYRIMIDIQUES ET LEUR UTILISATION COMME AGENTS ANTICANCÉREUX PUISSANTS
申请人:UNIV RAMOT
公开号:WO2008120205A1
公开(公告)日:2008-10-09
[EN] Novel N-acylated, O-acylated and (bis or tris)-N,O-acylated derivatives of purinic and pyrimidinic nucleoside analogs, pharmaceutical compositions containing same, and uses thereof for treating proliferative diseases or disorders are disclosed. [FR] La présente invention concerne de nouveaux dérivés N-acylés, O-acylés et (bis ou tris)-N,O-acylés des analogues de nucléosides puriques et pyrimidiques, des compositions pharmaceutiques les contenant, et leurs utilisations dans le traitement de maladies ou de troubles prolifératifs.